| 1.04 -0.01 (-0.95%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.3 | 1-year : | 1.52 |
| Resists | First : | 1.12 | Second : | 1.3 |
| Pivot price | 1.01  |
|||
| Supports | First : | 0.93 | Second : | 0.81 |
| MAs | MA(5) : | 1.04 |
MA(20) : | 0.98 |
| MA(100) : | 1.14  |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 76.6 |
D(3) : | 79.7 |
| RSI | RSI(14): 52.8 | |||
| 52-week | High : | 4 | Low : | 0.09 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HAO ] has closed below upper band by 37.2%. Bollinger Bands are 14.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.09 - 1.09 | 1.09 - 1.1 |
| Low: | 0.99 - 0.99 | 0.99 - 1 |
| Close: | 1.03 - 1.04 | 1.04 - 1.05 |
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.
Wed, 10 Dec 2025
Haoxi Health Technology Approves Major Shareholder Changes at December Meeting - TipRanks
Wed, 03 Dec 2025
Haoxi Health Technology Secures $5 Million in Private Placement - TipRanks
Wed, 03 Dec 2025
Haoxi Health Technology completes $5 million private placement of shares and warrants - Investing.com
Tue, 25 Nov 2025
Haoxi Health Technology Limited announced that it expects to receive $5 million in funding - marketscreener.com
Wed, 27 Aug 2025
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
Thu, 17 Apr 2025
Market Cool On Haoxi Health Technology Limited's (NASDAQ:HAO) Earnings Pushing Shares 29% Lower - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Communication Services
|
|
|
Industry:
Advertising Agencies
|
|
| Shares Out | 14 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 3.1 (%) |
| Held by Institutions | 0.1 (%) |
| Shares Short | 77 (K) |
| Shares Short P.Month | 74 (K) |
| EPS | 1.32 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6 |
| Profit Margin | 11.8 % |
| Operating Margin | -21.2 % |
| Return on Assets (ttm) | -6.8 % |
| Return on Equity (ttm) | 27 % |
| Qtrly Rev. Growth | -64.6 % |
| Gross Profit (p.s.) | 0.06 |
| Sales Per Share | 2.38 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 172.6 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | 0.78 |
| PEG Ratio | 0 |
| Price to Book value | 0.17 |
| Price to Sales | 0.43 |
| Price to Cash Flow | -4.26 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|